Press Releases

GARDP and Debiopharm Partner to Advance Development of Novel Gonorrhea Drug

StudentsPool fait rayonner l’innovation patients en remportant le 10ᵉ Challenge Qualité de vie du patient et reçoit le prix de…

Redefining Acromegaly Care: First Patient Randomized in Debiopharm’s Phase III OXTEND-03™ Trial of 3-Month Debio 4126 Treatment

Swiss-Based Debiopharm Seeks To Boost Innovation In Japanese Cancer Research Through The New “Ideal Japan” Program

Debiopharm Takes a Step Forward for Children with CPP: Enrollment Completion for the Phase III Trial Evaluating the First Ever…

Debiopharm Forges AI-Powered Alliance with NetTargets to Pioneer Dual-Payload ADCs Against Drug-Resistant Cancers

Debiopharm Leverages Risklick’s AI-Powered Solution to Improve Protocol Development Efficiency

Debiopharm Licenses SunRock Biopharma’s anti-HER3/HER2 Antibody to Explore the Full Potential of Bispecific ADC Debio 2512

Debiopharm Joins The Working Group Of The Naipo Initiative: Transforming Cancer Care With Artificial Intelligence